Precision Oncology starts with Precision Insights

Since Indivumed's founding over 20 years ago, we have prioritized high-quality samples as the cornerstone of our business. The latest article from our founder and CEO, Prof. Dr. Hartmut Juhl, recently published in the Winter 2024 edition of the European Biotechnology Magazine, refers about our unique database which allows for a full multi-omic view of cancer biology.

Read the complete article and find out about our multi-omic approach uncovering targets which would otherwise not be found.